Top 50 Health Care Startup Investors in Italy (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
CDP Venture Capital
VC Fund
|
27 | Italy, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $494k–$17M |
|
Club degli Investitori
VC Fund
|
15 | Italy, Switzerland, United Kingdom | Seed, Series A | Health Care, E-Commerce, Information Technology | $197k–$19M |
|
Italian Angels for Growth
VC Fund
|
15 | Italy, United States, United Kingdom | Seed, Angel, Series A | Software, E-Commerce, Health Care | $219k–$14M |
|
Panakes Partners
VC Fund
|
11 | Italy, Switzerland, United Kingdom | Series B, Series A, Series C | Health Care, Medical, Biotechnology | $4.4M–$110M |
|
Sofinnova Partners
VC Fund
|
10 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$120M |
|
Indaco Venture Partners
VC Fund
|
9 | Italy, Switzerland, United States | Series A, Series B, Series C | Biotechnology, Health Care, Life Science | $1.5M–$74M |
|
Innogest Capital
VC Fund
|
9 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
LIFTT
VC Fund
|
8 | Italy, United Kingdom, France | Seed, Series A | Software, Biotechnology, Manufacturing | $329k–$21M |
|
Principia SGR
VC Fund
|
8 | Italy, United States, United Kingdom | Series A, Seed | Health Care, Biotechnology, Software | $329k–$7.7M |
|
Claris Ventures
VC Fund
|
7 | Italy, United Kingdom | Seed, Series A, Series B | Biotechnology, Health Care, Life Science | $2.2M–$25M |
|
ENEA Tech e Biomedical
VC Fund
|
7 | Italy, Finland | Venture - Series Unknown, Series A, Grant | Health Care, Biotechnology, Medical Device | $530k–$21M |
|
Vertis
VC Fund
|
5 | Italy, United States, United Kingdom | Seed, Series A | Software, Computer, E-Commerce | $823k–$10M |
|
Healthware Ventures
VC Fund
|
5 | Italy, Austria, United States | Seed, Pre-Seed, Series A | Health Care, Personal Health, PaaS | $823k–$1.9M |
|
Invitalia Ventures
VC Fund
|
5 | Italy, United States, United Kingdom | Series A, Seed | Software, Medical, Internet | $658k–$6.2M |
|
Embed Capital
VC Fund
|
5 | Italy, Switzerland, United Kingdom | Seed, Pre-Seed | Information Technology, Mobile, Health Care | $132k–$2.1M |
|
P101
VC Fund
|
5 | Italy, Spain, United States | Seed, Series A | Software, E-Commerce, Information Technology | $236k–$15M |
|
A11 Venture
VC Fund
|
4 | Italy, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical Device, E-Commerce | $384k–$1.4M |
|
Italian Angels for Biotech
VC Fund
|
4 | Italy | Seed | Health Care, Biotechnology, Pharmaceutical | $549k–$2M |
|
The Techshop
VC Fund
|
4 | Italy, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, FinTech | $658k–$120M |
|
Pi Campus
VC Fund
|
4 | Italy, United States, United Kingdom | Seed, Pre-Seed | Software, Mobile, Biotechnology | $100k–$6.4M |
|
Andera Partners
VC Fund
|
3 | France, United States, Germany | Series B, Private Equity | Biotechnology, Health Care, Medical | $14M–$247M |
|
INGENIUM Emilia Romagna
VC Fund
|
3 | Italy | Seed, Angel | Medical, Health Care, Privacy | $2.1M–$2.2M |
|
Club Italia Investimenti 2
VC Fund
|
3 | Italy, United States, United Kingdom | Seed, Pre-Seed | E-Commerce, Software, Mobile | $55k–$576k |
|
Scientifica Venture Capital
VC Fund
|
3 | Italy, Sweden, Finland | Seed, Pre-Seed | Biotechnology, Health Care, Manufacturing | $209k–$2.9M |
|
Angelini Ventures
VC Fund
|
3 | United States, Italy, Switzerland | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $3.4M–$132M |
|
EUREKA! Venture SGR
VC Fund
|
3 | Italy | Seed, Pre-Seed | Nanotechnology, Manufacturing, Medical Device | $384k–$4.1M |
|
Atlante Ventures
VC Fund
|
2 | Italy, United States, Israel | Seed, Series A | Software, Biotechnology, Hardware | |
|
Neva SGR
VC Fund
|
2 | Italy, Israel, United States | Series A, Series B | Software, FinTech, Financial Services | |
|
Alchimia Investments
VC Fund
|
2 | Italy, United Kingdom, Israel | Series A, Seed | Health Care, Medical, Artificial Intelligence | |
|
Rancilio Cube
VC Fund
|
2 | United States, Italy, Germany | Seed, Series A, Series B | E-Commerce, Software, Financial Services | |
|
Sullivan Ventures
VC Fund
|
2 | Italy | Pre-Seed, Seed | Health Care, Mental Health, Translation Service | |
|
Sergio Liscia
Angel
|
2 | Italy | Seed, Pre-Seed | Health Care, Mental Health | |
|
Luca Trevisan
Angel
|
2 | Italy | Series A | Medical, Health Care, Medical Device | $750k–$1.3M |
|
Luca Foresti
Angel
|
2 | Italy | Pre-Seed | SaaS, Retail, Nutrition | |
|
Fin Posillipo Spa
VC Fund
|
2 | Italy | Seed | Medical, Wellness, Health Care | |
|
Dino Giusti
Angel
|
2 | Italy | Seed | Wellness, Health Care, Medical Device | $549k–$987k |
|
Stefano Bernardi
Angel
|
2 | Italy, United Kingdom, France | Seed, Pre-Seed | Software, Biotechnology, Artificial Intelligence | $100k–$45M |
|
StartUp Health
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Pre-Seed | Health Care, Wellness, Medical | $20k–$4M |
|
Fresco Capital
VC Fund
|
2 | United States, Hong Kong, China | Seed, Series A | Software, Education, SaaS | $500k–$15M |
|
Wolsey Ventures
VC Fund
|
2 | Italy, United States, United Kingdom | Series A, Angel, Pre-Seed | Health Care, Legal, Fashion | $220k–$12M |
|
Andrea Dusi
Angel
|
2 | Italy, United States, United Kingdom | Seed, Pre-Seed, Series A | Biotechnology, Health Care, CleanTech | $150k–$15M |
|
CDP Equity
VC Fund
|
2 | Italy, United Kingdom | Seed, Series A | SaaS, Beauty, Events | $2.7M–$4M |
|
Simon Fiduciaria
VC Fund
|
2 | Italy, India, Switzerland | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $555k–$7.6M |
|
Lumen Ventures
VC Fund
|
2 | Italy | Seed, Series A, Pre-Seed | Health Care, Medical, InsurTech | $1.3M–$14M |
|
3B Future Health Fund
VC Fund
|
2 | United States, Italy, United Kingdom | Series B, Series A | Biotechnology, Therapeutics, Medical | $2.7M–$43M |
|
Primo Capital
VC Fund
|
2 | Italy, United States, United Kingdom | Seed, Series A | Software, Aerospace, Information Technology | $329k–$28M |
|
Equiter
VC Fund
|
2 | Italy | Seed, Series B | Medical, Health Care, Information Technology | $2.2M–$3.8M |
|
UniCredit
VC Fund
|
2 | Italy, Germany, Spain | Debt Financing, Post-IPO Debt | Manufacturing, Renewable Energy, Energy | $521k–$1.4B |
|
NovaCapital
VC Fund
|
2 | Italy, Israel, Austria | Seed, Series A, Pre-Seed | Software, Health Care, Manufacturing | $137k–$40M |
|
Growth Engine
VC Fund
|
2 | Italy, Mexico, United Kingdom | Seed, Secondary Market, Pre-Seed | Software, E-Commerce, Information Technology | $300k–$4.2M |
| Access all 427 investors in Italy Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 245
- Round size: Seed $494k–$8.2M; Series A $3.3M–$17M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $197M in 2021
Portfolio highlights
- Mopso — Discover Mopso's anti money laundering detection system. Visit our website and try a 30 minutes free demo with one of our experts.
- CamGraPhIC — Our platform supports the ever-increasing data traffic demand with high-performing and low-power consumption electro-optical engines.
- Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.
Show more...Investment focus
- Industry: Health Care, E-Commerce, Information Technology
- Stage:Seed, Series A
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 96
- Round size: Seed $197k–$7.6M; Series A $889k–$19M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Largix — Largix is the first company to develop and commercially produce 3D Robotic Printers for real production processes. We have invented the "Cold 3D Printing®" technology that makes 3DP possible for real industrial production. Largix uses the most common thermoplastic polymers: Polypropylene and Polyethylene, polymers that nobody else iscapable of printing.
- Spacest.com By Roomless — Rent directly online with Roomless, the safe and simple platform for those looking for a house for rent.
- Approxima — Approxima medical is developing a novel treatment for patients with tricuspid valve regurgitation
IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 103
- Round size: Seed $329k–$5.9M; Angel $219k–$1.2M; Series A $2.7M–$14M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Cato AI — Cato AI is a Milan-based B2B SaaS startup that uses AI to automate public tender management.
- Fitprime — Il Partner unico per il Wellbeing Aziendale
- Alomana —
Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250million under management.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series B, Series A, Series C
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 42
- Round size: Series A $4.4M–$79M; Series B $9.9M–$60M; Series C $18M–$110M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
- CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 309
- Round size: Series A $6M–$67M; Series B $10M–$120M; Series C $12M–$100M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- Elicit Plant — We work with farmers around the world to meet the challenges of climate change and the impact of water scarcity on field crops.
- l'école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
- EndoRon Medical — Endoron Medical develops an endovascular suture, like a device for the effective treatment of an abdominal aortic aneurysm.
VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B, Series C
- Geography: Italy, Switzerland, United States
Investor stats
- Total investments: 42
- Round size: Series A $1.5M–$31M; Series B $8.8M–$52M; Series C $16M–$74M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
- CamGraPhIC — Our platform supports the ever-increasing data traffic demand with high-performing and low-power consumption electro-optical engines.
- Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Prestiamoci — Prestiamoci is the first community of loans between individuals born in Italy, allowing you to make profitable investment and to obtain loans with installments transparent.With Prestiamoci the providers invest and get Claimants, returning to its original role of the bank safe. Loans shall be paid by people to trustworthy people who want toachieve their life projects, grow their professional activity, better manage expenses and major purchases
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Series A
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 71
- Round size: Seed $329k–$4.7M; Series A $2.7M–$21M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
- Maieutical Labs — I Maieutical Labs sono un insieme di piattaforme ispirate al Mastery Learning, immersive e mobile-oriented, dedicate allo studio nella scuola secondaria
- RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 50
- Round size: Seed $329k–$3.3M; Series A $1.5M–$7.7M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $187M in 2014
Portfolio highlights
- KLISBio — KLISBio is a medtech company currently developing a variety of regenerative medicine implantable products leveraging the power of silk fibroin to promote an endogenous repair of human soft tissues.
- ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Series A, Series B
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 15
- Round size: Seed $2.2M–$11M; Series A $6.1M–$25M; Series B $7.9M–$20M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- Haptena Therapeutics — Haptena Therapeutics is a biotechnology company developing innovative approaches for genetically defined cancers.
- Resalis Therapeutics — Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Series A, Grant
- Geography: Italy, Finland
Investor stats
- Total investments: 13
- Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
Vertis is a dynamic and independent investment management company authorised by Bank of Italy. It manages five closed-end funds for qualified investors by participating in research projects, spin-offs, startups and PMI and deals with the investments of the innovative Made in Italy.
Show more...Investment focus
- Industry: Software, Computer, E-Commerce
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 65
- Round size: Seed $823k–$3.6M; Series A $1.5M–$10M
- Lead/follow: 58% lead, 42% follow
- Last fund: Likely still investing — raised $35M in 2021
Portfolio highlights
- Quido AI — Quido is the co-pilot for investment professionals. Quido allows private capital professionals to streamline data retrieval and data analysis and dramatically increase their efficiency.
- Focoos AI — Focoos reshapes computer vision with ultra-efficient models that drive down costs, automate hardware integration, and ensure peak performance on any device, while promoting sustainability.
- TimeFlow — TimeFlow is a software that acts as a B2B marketplace dedicated to the technical and managerial consulting sector.
Healthware Ventures is the corporate venture capital arm of Healthware Group
Show more...Investment focus
- Industry: Health Care, Personal Health, PaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, Austria, United States
Investor stats
- Total investments: 7
- Round size: Seed $823k–$1.9M; Pre-Seed $1M–$1.3M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- PatchAi — Improve patient engagement and experience in clinical trials and standard care. Discover Patchai solution.
- 1000Farmacie — 1000Farmacie is the leading Pharmacy Marketplace in Italy. Though a network of independent Pharmacies we deliver faster!
- YourCoach Health — Health and Wellness coach practice management solution enabling coaches to holistically lead their clients, connecting mind, body and soul through behavior modification and accountability tools towards outcomes
Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it
Show more...Investment focus
- Industry: Software, Medical, Internet
- Stage:Series A, Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Seed $658k–$1.6M; Series A $900k–$6.2M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — raised $89M in 2017
Portfolio highlights
- Ecomate — The ESG Rating platform for every company
- BigProfiles — A deep understanding of customers let a company tailor marketing campaigns and CRM strategies, but companies have only basic data about customers (e.g. gender or age). External data sources like Social Networks, Public Registries and Socio-Demographic data contain rich information about billions of people, like job titles, levels of education,interests and habits.BigProfiles is a Customer Intelligence SAAS that leverages external information about persons to enrich customer profiling: it can profile a company's customers with previously unknown information about them. Thanks to its Identity Resolution algorithm (the result of a PHD), it identifies a person’s information scattered among external sources.Through this technology, BigProfiles provides customer base analytics and behavior predictions: using Artificial Intelligence on enriched profiles allows to predict churn, fraud and willingness to buy.
- Codemotion — Codemotion is the ecosystem devoted to innovation, focused on developers and coding, open to all programming languages and technologies. Pioneering spirits, it scout the future to deliver a first class experience to our people. Codemotion is one of the biggest tech-conferences in Europe, with an international network of 30.000 developers and 350speakers coming from all over the world and from the most important IT realities.Codemotion draw in its main conferences, thousands of attendees eager to discuss about hottest topics: it tailor for them disruptive proposals ranging from mobile to UX, develops, cloud, big data, gamedev, security, methods, languages, web, Internet of things. Codemotion is also a startup, providing a bunch of services and activities, for personal and business customers.
Embed Capital directly invests in startups, established or in the process of creation.Embed is mainly focused on innovative companies that:- Are active in the so-called “real economy” sectors: industrials, technology, environment, services, retail or social;- Are characterized by simple and intuitive business models and valuepropositions, and operate in markets or market segments featuring high growth potential;- Present a clear competitive advantage and high barriers-to-entry;- Are cash-generative in the medium term.Given that Embed Capital is not a closed-end fund, it doesn’t have specific time-constrains and it can assess on a project-by-project basis to determine the best time to sell a participation, and sign customized agreements with the entrepreneurs.
Show more...Investment focus
- Industry: Information Technology, Mobile, Health Care
- Stage:Seed, Pre-Seed
- Geography: Italy, Switzerland, United Kingdom
Investor stats
- Total investments: 17
- Round size: Seed $132k–$2.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Piantando — Piantando sells plants connected to initiatives for the preservation of the planet engaged in the following areas: land, water, climate, biodiversity and local communities. Each plant is equivalent to a transparent and unique contribution, destined to an initiative certified by our Value Chain. Everyone become ambassadors of a new way of livinggreen and understanding their commitment to the planet.
- FrescoFrigo - Healthy food close to you — FrescoFRIGO is a smart fridge with fresh and quality products designed for the needs of worker. Improve everyday lifestyle, through automated proximity selling of good, fresh and healthy product, innovating technology and user experience.
- The Nemesis — The Nemesis is the playground for play-to-earn games and adventures in virtual worlds. Accessible on both mobile and desktop.
P101 is an Italian venture capital firm focused on early-stage investments in the digital sector. Agreement to handle personal data I agree I don't agree
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A
- Geography: Italy, Spain, United States
Investor stats
- Total investments: 110
- Round size: Seed $236k–$4.1M; Series A $2.1M–$15M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Cosmico — We are the platform connecting digital talents with the most ambitious companies, using remote work.We have over 8,000 members and our talents have accelerated dozens of projects alongside big names like Accenture Song, Tangity, Frog, Fjord, Sketchin, EY but also aggressive start-ups like Scalapay, Gimme5, Flowe, Unguess.If you are a digitalprofessional: we offer you a community in which to grow your talent through experiences, networks and cosmic projects.If you are a company: we offer you access to a community of designers, developers and marketers from which to select the talents to accelerate your digital transformation projects. Whether you are a manager or a digital professional, Cosmico is here to help you find your space
- A-Cube — A-Cube is a software company that provides digital solutions to exchange documents with government agencies.
- Incapto Coffee — Incapto Coffee offers the sale of the automatic coffee machine and a subscription system for coffee beans.
A11-Venture investe nel capitale di startup innovative nei settori della robotica, automazione, meccatronica, cleantech, web e IT. Facilita la nascita e lo sviluppo di business innovativi globali per il futuro dell'economia locale. Contribuisce a costruire aziende, lavoro qualificato, brevetti, innovazione capaci di rilanciare e riportareinvestimenti e risorse sul territorio. I soci di A11 Venture credono fermamente nell’innovazione grazie a ciò è possibile crescere per linee esterne diversificando i propri investimenti, grazie ad un portafoglio di imprese, con una forte risk mitigation derivante dalla gestione professionale di tutti processi: scouting, team building, investimenti, management degli investimenti, accelerazione e disinvestimento.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States
Investor stats
- Total investments: 13
- Round size: Seed $384k–$1.4M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Reefilla — Reefilla EV charging services: recharge your car anywhere, anytime
- Endostart — Endostart development and manufacturing of a new generation medical devices for gastrointestinal endoscopy.
- Neuron Guard — Neuron Guard, recognized as the best European startup in HEALTH category (Startup Europe Awards - SEUA 2017), is developing a life-saving medical device that aims to become the standard of care for Targeted Temperature Management (TTM) therapy. Every 7 seconds around the world a person suffers of Acute Brain Damage because of CardiovascularDiseases (CVD) and Traumatic Brain Injury (TBI). They are the most costly and prevalent killers in the last 15 years (15 million deaths by CVD in 2015), and the leading cause of disability (the global incidence rate of TBI is 200 per 100k people per year). WHO estimated a global expenditure of $ 330 billion in 2015, but it is going to increase sharply: $ 4 trillion in 2025 - including premature death, disability, and health care costs - just for CVD in LMICs. Temperature is a vital body parameter. It regulates all cellular functions so its management is essential for the good outcome of patients in several medical conditions such as cardiac arrest, stroke, traumatic brain injury, neuro and cardiac surgery, epilepsy, migraine and oncology. Regulating body temperature at a desired level makes all other treatments more effective. The most modern medical approach is the target temperature management, where physicians try to maintain the most favourable temperature for the patient for up to 24-36 hours, preventing excessive warming (fever) or cooling.Our device is a targeted temperature management system composed by a THERAPEUTIC COLLAR POWERED BY A SMART CONTROL UNIT (the size of a small briefcase). The collar transforms the neck into a natural heat exchanger exploiting several physiological and anatomical characteristics of the human body. It is quicker to act on brain tissue but can also function as total body temperature adjusting device if required. A disposable protective shield makes cleaning the collar after each use simple while featuring an optimal safety profile both in term of pathogens and allergens. The control unit collects all the data of the treatment and transmits them to the Emergency Response System. Our mission is to improve the safety of patients on the roadside, at home or in the workplace, and to reduce the costs of chronic care. In fact, Neuron Guard aims to be the only device that can be used in every circumstance, inside and outside the hospital, and allow the user to fully manage the temperature of the patient warming and cooling as necessary. Our vision is to have a Neuron Guard kit in every public place just like the Automatic External Defibrillator (AED) to empower bystanders to immediately react in case of emergency. Under this perspective our device becomes a connected-intelligent platform that takes care of the patient, connects the scene with the Emergency Response System transmitting vital data to improve the readiness and effectiveness of professional intervention.The device is patented in Italy, USA and China. We have made several prototypes in collaboration with Italian and English companies, such as Tecno Elettra Impianti and TWI, tested it in laboratory and published the experimental results on the NeuroCritical Care Journal. We have also conducted a GAP Analysis with another English consulting firm (CDP) and we are testing the human prototype internally. We are seeking to raise 2.5M€ to complete the pre-industrialization, with design and construction of the human device for the pilot trial, finalized the regulatory clearance and launch it into the market in 2019.
Angel group focuses on biotech
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 4
- Round size: Seed $549k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
- Metis Precision Medicine — Metis Precision Medicine is a B-Corp founded with the vision of bringing powerful cancer therapies to patients in need. Metis owns the intellectual property of a suite of anti-Met monoclonal antibodies (mAbs), with different and unique mechanisms of action, and is currently seeking investors, biotech or pharmaceutical companies interested inacquiring the relevant platform technology on a global basis.
The Techshop is a venture capital and private equity firm that invests in B2B digital startups.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 23
- Round size: Seed $658k–$8.2M; Pre-Seed $658k–$38M; Series A $8.2M–$120M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- hlpy — hlpy operates as a roadside assistance company. Hlpy provides a digital roadside assistance service via a network of 580+ centers, 1,900+ drivers/mechanics, 2,800+ tow trucks.
- Smartness — Smartpricing is a provider of computer software application and revenue management system solutions to Hotel.
- Sustainable Brand Platform — Sustainable Brand Platform is the sustainability intelligence solution for fashion brands and manufacturers to accurately measure and manage their sustainability performance.
Pi Campus is a startup district and a venture fund that invests in talent. We provide startups with money, mentorship and the best work environment for growth.
Show more...Investment focus
- Industry: Software, Mobile, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 52
- Round size: Seed $125k–$6.4M; Pre-Seed $100k–$1.6M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Loquis — La prima piattaforma per ascoltare e raccontare il mondo tramite podcast geolocalizzati
- Intron Health — Voice AI Built for How Africa Speaks Our next-generation intelligent voice model built from the ground up for AfricaUnlike Global systems retrofitted for the continent Sahara v-2 understands how Africa actually sounds Build with Sahara Try Sahara Built for African SpeechFrom Lagos Call Centers, to Hospitals in Nairobi, Boardrooms in Cape Town, and Courtrooms in
- Cyberwave — Transform your industry with AI-defined robotics. Frictionless automation that makes advanced robotics accessible to manufacturers of all sizes.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity
- Geography: France, United States, Germany
Investor stats
- Total investments: 179
- Round size: Series B $14M–$85M; Private Equity $110M–$247M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $466M in 2022
Portfolio highlights
- Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
- ImCheck Therapeutics — ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
- Greywolf Therapeutics — Novel antigen modulation technology that controls T cells to guide the immune system
INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.
Show more...Investment focus
- Industry: Medical, Health Care, Privacy
- Stage:Seed, Angel
- Geography: Italy
Investor stats
- Total investments: 5
- Round size: Seed $2.1M–$2.2M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
- GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
- Angiodroid — Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy.
Club Italia Investimenti is a Milan-based venture capital firm that assists startups in raising seed capital.
Show more...Investment focus
- Industry: E-Commerce, Software, Mobile
- Stage:Seed, Pre-Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 81
- Round size: Seed $55k–$576k; Pre-Seed $110k–$219k
- Lead/follow: 1% lead, 99% follow
- Last fund: May invest from a new fund soon — raised $5.9M in 2013
Portfolio highlights
- UNGUESS (formerly AppQuality) — UNGUESS is the crowdsourcing platform for effective testing and real insights. Take the guesswork out of your work.
- Paragraph — Powerful stories and powerful storytellers. Each week find seven of the world's best shorts in text, audio, and video: http://bit.ly/1usXQd5
- La Passione — High quality Italian Road and Urban cycling wear at fair prices. We use only the finest materials and sell direct to you with no middleman. Shop now!
Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Seed, Pre-Seed
- Geography: Italy, Sweden, Finland
Investor stats
- Total investments: 14
- Round size: Seed $553k–$2.9M; Pre-Seed $209k–$541k
- Lead/follow: 71% lead, 29% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
- OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
- LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
Angelini Ventures is an investment firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, Italy, Switzerland
Investor stats
- Total investments: 26
- Round size: Seed $3.4M–$13M; Series A $5.7M–$105M; Series B $26M–$132M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- CoMind — Our mission is to redefine the way the brain is measured and treated to optimise patient outcomes across the care continuum.
- Vantis — Vantis GmbH is a Digital solution for Chronic cardiovascular diseases that requires personalized ongoing treatment for decades.
- Avation Medical — 42 million men and women have symptoms of OAB and incontinence. Vivally can help.
Eureka! is the first independent Italian venture capital Asset Management company exclusively focused on deep tech investments
Show more...Investment focus
- Industry: Nanotechnology, Manufacturing, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 32
- Round size: Seed $384k–$4.1M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- FLEEPtech — FLEEP Technologies designs and develops printed electronics solutions for the biomedical and smart packaging sectors. The company, spin-off of Istituto Italiano di Tecnologia, was founded in May 2019.FLEEPtech developed a proprietary process for the fabrication of polymer-based integrated circuits based on Organic Thin-Film Transistors, creatingthe intelligent core for electronics systems that are mechanically flexible, printed like magazines and recyclable. FLEEPtech is the missing link in the printed electronics industry between a great number of flexible and printed products (i.e. sensors, actuators and energy supplies) that find little space in being integrated with standard non-flexible electronics. For such reasons, the company's mission revolves around the realization of a general purpose platform for the manufacturing of fully-printed integrated systems, composed by printed sensors, printed actuators, printed energy supplies and harvesters and, of course, printed integrated circuits.
- Novac — Progettiamo supercondensatori da affiancare alle batterie, per incrementare performance ed efficienza dei veicoli elettrici.
- INTA Systems — Nanotech and artificial intelligence for biomolecular analysis
Atlante Ventures is a leading Italian VC fund, operated by IMI Fondi Chiusi SGR, part of Intesa Sanpaolo Group.
Show more...Investment focus
- Industry: Software, Biotechnology, Hardware
- Stage:Seed, Series A
- Geography: Italy, United States, Israel
Investor stats
- Total investments: 45
- Lead/follow: no public data
Portfolio highlights
- treet — Treet helps brands launch fully-branded recommerce sites where customers can buy & sell items from each other.
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Neva SGR, part of the Intesa Sanpaolo Group and wholly owned by the Intesa Sanpaolo Innovation Center, plans and manages investment funds for professional investors interested in seizing diversification and high-yield opportunities offered by Venture Capital investments. Neva SGR can count on Intesa Sanpaolo Innovation Center’s and Intesa SanpaoloGroup’s strength, financial resources, know-how and network of relationships, a unique source of value on the market. Neva SGR is the perfect blend of strength, reputation and stability of the Intesa Sanpaolo Group and the best practices of international venture capital firms. Neva SGR aims to boost the Italian economy through new technologies and to be market maker of the VC asset class of venture capital in Italy.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Series A, Series B
- Geography: Italy, Israel, United States
Investor stats
- Total investments: 31
- Lead/follow: no public data
Portfolio highlights
- Casavo — Want to sell your house fast? Fill out the online form and receive a free home value estimate and real estate prices from Casavo!
- NeoPhore — NeoPhore targets the dynamics of cancer neoantigen evolution and makes effective medicines that will become a key part of the next-generation of cancer immunotherapies.
- BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Alchimia is an investment company primarily operating in the Venture Capital Sector. Leveraging the expertise of our team and a wide network of international advisors, we invest and co-invest in high growth potential opportunities offering capital, as well as dedicated strategic and operational resources.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Seed
- Geography: Italy, United Kingdom, Israel
Investor stats
- Total investments: 18
- Lead/follow: no public data
Portfolio highlights
- NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
- Prestatech — Prestatech is a digital credit factory that has developed an innovative underwriting platform for banks and financial institutions in Europe. Currently active with major European banks, Prestatech offers them a variety of digital credit services from data enrichment to end-to-end instant lending solutions. Thanks to technological innovation,Prestatech has gained an extensive expertise in the digital credit space and through its open-platform is currently offering API-based solutions that leverage on AI, advanced algorithms and Big Data technologies.
- Chiara Ferragni — COM Chiara Ferragni
Cube is the investment office founded by Rancilio family
Show more...Investment focus
- Industry: E-Commerce, Software, Financial Services
- Stage:Seed, Series A, Series B
- Geography: United States, Italy, Germany
Investor stats
- Total investments: 66
- Lead/follow: no public data
Portfolio highlights
- Convoy — Using technology and automation, the Convoy Platform seamlessly connects carriers with shipments from brokers across the nation.
- FinCompare - Smarter Business Finance — FinCompare was founded by Stephan Heller and is a fintech startup that helps businesses to find, compare, and close the financing solutions. Via the online platform, companies can access a wide range of financing options. They can independently compare offers from well-known banks, fintechs, and alternative financial services providers in Germanyand close the financing. The company also offers a convenient one-stop destination for all financing questions relating to the company.FinCompare financing solutions including corporate loan, factoring, company leasing/hire purchase, warehouse financing, fine trading/purchase financing, and mezzanine capital. It simplifies the financing process with its digital application process and can thus provide your company financing. The company allows SMEs to receive and compare various offers for loans.FinCompare was founded in October 2016 by Stephan Heller and is headquartered in Berlin, Germany.
- Finom — Finom is an online payment solution for entrepreneurs that makes it easy to open a business account and securely manage their finances.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sullivan Ventures is a investment firm.
Show more...Investment focus
- Industry: Health Care, Mental Health, Translation Service
- Stage:Pre-Seed, Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Wayla — Wayla offre viaggi serali sicuri e sostenibili a Milano con il primo servizio di van pooling. Prenota tramite app e viaggia a bordo dei nostri van con autisti certificati a tariffe vantaggiose
- Lilac-Centro DCA — Lilac-Centro DCA is a digital health tech firm founded by a group of specialists who treat anorexia, bulimia, binge eating disorder.
Sergio Liscia is an angel investor.
Show more...Investment focus
- Industry: Health Care, Mental Health
- Stage:Seed, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lilac-Centro DCA — Lilac-Centro DCA is a digital health tech firm founded by a group of specialists who treat anorexia, bulimia, binge eating disorder.
Luca Trevisan Sales Manager and Business Coordinator.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Italy
Investor stats
- Total investments: 2
- Round size: Series A $750k–$1.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- I-VASC — I-VASC has developed the VELEX device using new technology to treat CVI and varicose veins.
Luca Foresti is the CEO at Santagostino. Luca Foresti attended The University of Pisa.
Show more...Investment focus
- Industry: SaaS, Retail, Nutrition
- Stage:Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Tuduu — Tuduu.it: Revolutionizing the Internationalization of Italian Food E-commerceTuduu.it is an innovative internationalization-as-a-service platform designed to empower small and medium-sized Italian food producers to overcome the digital and linguistic barriers that limit their global reach. By providing a scalable AI-powered ecosystem, Tuduuenables these producers to seamlessly translate, enrich, and showcase their product catalogs and recipes in over 17 languages, unlocking new export opportunities across Europe and beyond.The Challenge The Italian agri-food sector is a global leader, generating over €523 billion in turnover and employing 3.6 million people. However, only 15% of this turnover currently derives from exports, and just 20% of Italian food companies have an e-commerce presence — often limited to Italian language only. This poor digitalization and language gap create significant competitive disadvantages for many small and medium producers eager to reach international customers.Tuduu’s Solution Tuduu.it addresses these challenges through a comprehensive, AI-driven digital platform designed as an internationalization-as-a-service (IaaS) model for Made in Italy food e-commerce. The key pillars of Tuduu’s solution include:AI-powered catalog and recipe translation: Automatic, scalable translation of product catalogs, recipes, and user-generated content (UGC) videos into 17 languages, including automated dubbing of video content, enabling producers to speak directly to diverse international markets.Personalized user experience: Dynamic nutrition filters allow users to explore products and recipes tailored to their dietary profiles (e.g., vegan, gluten-free, allergies), with AI algorithms that automatically determine macro- and micronutrients, and assess nutritional compatibility with specific dietary restrictions.Seamless marketplace integration: Producers set up or maintain their own e-commerce sites and access Tuduu’s ecosystem by installing a simple plugin or API feed. This approach preserves producers’ autonomy while enabling them to benefit from Tuduu’s unique international visibility and user engagement.Recipe-driven commerce: Tuduu innovates by combining product discovery with rich recipe content, allowing consumers to explore authentic Italian culinary experiences and directly purchase ingredients through integrated shopping lists and seamless checkout flows.SEO and marketing optimization: Tuduu acts as a multilingual media showcase optimized for both Google search and YouTube video discovery, leveraging AI-generated content and influencer marketing networks to boost brand awareness and export sales.Market Opportunity 54,000+ Italian food companies generate approximately €67 billion in export value annually.The total addressable market (TAM) of the Italian agri-food sector is €523 billion, with the serviceable available market (SAM) focused on the digitally mature segment estimated at €12 billion.Tuduu’s projected serviceable obtainable market (SOM) aims to capture €11.4 million in transactions within five years, with a target of more than 800 retailers and 90 million euros in transaction volume.Business Model Tuduu operates primarily on a performance-based affiliation fee of 10% on sales, coupled with a SaaS subscription starting at €99/month for access to advanced platform features. Custom projects and media services (including influencer campaigns) are offered to support brand promotion and growth.The Tuduu Ecosystem and Team The platform is built on three key scalable AI models:Product Model: Analyzes and translates product data with nutritional profiling and cross-contamination detection.Recipe Model: Automates recipe nutrient calculation and compatibility with specific dietary needs.Nutrition Model: Generates personalized nutrition plans and profiles.The Tuduu team combines expertise in food tech, software development, UX design, marketing, and business development, driven by a shared mission to support Italian food producers’ digital transformation and international expansion.Sustainability and Impact Tuduu embraces sustainability not only as a goal but as a driver of growth. By promoting healthier eating habits through nutritionist-guided recipes and improving access to authentic local products, Tuduu aligns with several United Nations Sustainable Development Goals (SDGs). The platform also supports small producers by facilitating their entry into global markets via digital channels, thereby enhancing social and economic sustainability in local communities.Side Project: Tuduu Nutrition Expanding the core technology, Tuduu has developed a complementary SaaS platform for nutritionists called Tuduu Nutrition. This platform enables rapid creation, analysis, and digitization of personalized nutrition plans, integrated into a mobile app for patient compliance and monitoring.Key features of Tuduu Nutrition include:Generation of tailored nutrition profiles and plans based on validated dietary guidelines.Weekly meal planning with integrated recipes from Tuduu’s extensive database.Shared and collaborative shopping lists that automatically sync with partner retailers for easy purchasing.SaaS pricing based on a monthly subscription (€29/month) plus a fee per managed patient (€2.5/month).Tuduu Nutrition leverages the same AI technology and data models as Tuduu.it, creating synergy between food e-commerce and health-oriented nutrition planning.Financial Outlook and Fundraising Tuduu is currently in a growth and fundraising phase, targeting €1,000,000 in capital with investment tickets starting from €5,000. The company projects rapid scaling with increasing revenues from marketplace transactions, media services, and SaaS subscriptions, aiming for over €11 million in revenues by 2029 and expanding its brand network substantially.Summary Tuduu.it is poised to transform the Italian food export landscape by bridging the gap between small producers and international consumers through advanced AI-driven digital tools, an engaging marketplace experience, and a strong commitment to sustainability and nutrition. Alongside its sister platform Tuduu Nutrition, it creates a comprehensive ecosystem that connects producers, consumers, and health professionals in a unique, scalable way.
- Jet HR — Jet HR makes managing people incredibly simple: payroll, benefits, devices, compliance and much more. We re-thought the HR function, removing anything that is cumbersome and simplifying any action on employees. We are funded by the best Italian VCs (Exor Ventures, Italian Founders Fund and 6 more) and by the best Italian founders (founders ofCasavo, Satispay, Scalapay, Bending Spoons, Musixmatch, Talent Garden, Oyster HR, etc).
Familiy Office of Petrone Group
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- BetaGlue Technologies — BetaGlue Therapeutics is a life sciences company that delivers radiotherapy from within. Introducing Yntradose, our proprietary product.
Dino Giusti
Show more...Investment focus
- Industry: Wellness, Health Care, Medical Device
- Stage:Seed
- Geography: Italy
Investor stats
- Total investments: 2
- Round size: Seed $549k–$987k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Euleria Health — Devices and technologies for more accessible and measurable rehabilitation and telerehabilitation at the service of clinics and movement experts, in the clinic and at home.
Stefano Bernardi is the Investment Director, Climate at Fondazione ENEA Tech.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Italy, United Kingdom, France
Investor stats
- Total investments: 17
- Round size: Seed $100k–$45M; Pre-Seed $1.4M–$2.2M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- iubenda — Make your sites & apps legally compliant across multiple languages and legislations (including the GDPR) with our lawyer-crafted, self-updating solutions.
- Eden Bio — Eden Bio is a biotech using machine learning to guide the genetic engineering of microorganism strain optimisation, improving protein yield.
- Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots
Show more...Investment focus
- Industry: Health Care, Wellness, Medical
- Stage:Seed, Pre-Seed
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 194
- Round size: Seed $100k–$4M; Pre-Seed $20k–$800k
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Jiseki Health — Jiseki is built on the belief that families and communities need and deserve a safety net, and to have peace of mind when things go wrong. We provide access and delivery of key advice, help, products and services through highly scalable SMS technology, powered by a combination of professionals and AI, and sold as a portable life benefit package..Text #help to 543210, to discover Jiseki services.
- Biome Analytics — Biome is an analytic applications that help cardiovascular teams do their best work. It helps forward thinking hospitals profitably transition and thrive in the new world of healthcare. During COVID-19, Biome has focused on assessing hospital capacity.
- NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Investing at the intersection of people and technology.
Show more...Investment focus
- Industry: Software, Education, SaaS
- Stage:Seed, Series A
- Geography: United States, Hong Kong, China
Investor stats
- Total investments: 100
- Round size: Seed $500k–$3.1M; Series A $2M–$15M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Reap — Reap helps you pay expenses using a credit card, collect payments from around the world, and improve your expense and cash flow management. All in one platform.
- Subscript — Create, understand, and tell the story of your subscription business through numbers.
- AlwaysHired — Cost neutral sales hiring solutions for employers. Join top tech companies.
We lead, co-lead and at times just partecipate and invest anywhere in all pre-venture and series A rounds, helping organizations become enduring businesses.Yet entrepreneurs and investors aspire to learn from each other and remain inspired.Our mission at Wolsey Ventures consists in technology startups.We believe adoption of smart, digital andhigh technologies will continue to rise in 2016 and beyond,to meet demands from consumers and pressure from the competition to perform and adapt.This demand creates many opportunities for fast-growing companies to start up and reach a global scale.
Show more...Investment focus
- Industry: Health Care, Legal, Fashion
- Stage:Series A, Angel, Pre-Seed
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 5
- Round size: Pre-Seed $220k–$235k; Series A $1.7M–$12M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- SurgiQ — SurgiQ strives to make surgical pathways more effective, less invasive and easier on surgeons, patients, and their families. We help healthcare providers being more efficient and deliver timely care by providing an innovative audit and planning platform supported by AI algorithms.
- Tossed — Healthy eating doesn't have to be boring with our delicious hot pots, house salads, power bowls & rainbow wraps made with fresh vegetables, lean protein & low GI carbs.
- AirHelp — AirHelp is an online legal service that helps air passengers get compensation from airlines when their flight gets canceled, delayed, or overbooked. Passengers can access the service via its official Facebook page or its mobile app available for iOS and Android devices.AirHelp takes care of all the paperwork and legal communications with theairline on behalf of the passengers and claims 25% of the compensation obtained as its service fee. The compensation amount varies between $170 to $650 based on the distance flown by the flight and the duration of the delay experienced by the passenger at the final destination.AirHelp was launched in 2013 by Greg Roodt, Henrik Zillmer, and Nicolas Michaelsen.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Entrepreneur and investor. After working in management consulting, in 2006 he created Wish Days, known above all for the Emozione3 gift boxes. In April 2016, he sold the company to the Smartbox group with a millionaire exit. In 2017, together with Cristina Pozzi, already a partner in Wish Days he founded Impactscool.He is advisor of dozens oftechnological initiatives and business angels in 150+ startups focusing on clean tech.He is the author of the book “Come far fallire una startup ed essere fellici” – How to make a startup fail and be happy, published by Bompiani, Bestseller in 2018.
Show more...Investment focus
- Industry: Biotechnology, Health Care, CleanTech
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 15
- Round size: Seed $150k–$6M; Series A $3.8M–$15M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Talyn Air — Inspired by two-stage rockets, our innovative eVTOL uses two flight vehicles to transform flight. Fixed-wing performance with VTOL capabilities.
- BillionToOne — We are a team at the forefront of disease detection focused on moving Prenatal Screening and Liquid Biopsy forward.
- CaSRevolution — A novel disease-modifying approach against neurodegeneration
CDP Equity is a holding company that has been set up to boost the Italian economy by investing venture capital in companies of "significant national interest" (as envisaged by the decrees of the Ministry of Economy and Finance of 3 May 2011 and 2 July 2014) or in companies with "economic, financial and capital balance, with adequateprospects of profitability and development, capable of generating value for investors"
Show more...Investment focus
- Industry: SaaS, Beauty, Events
- Stage:Seed, Series A
- Geography: Italy, United Kingdom
Investor stats
- Total investments: 9
- Round size: Seed $3.3M–$4M; Series A $2.7M–$3.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
- Neuranix — Neuranix develops, manufactures, and markets innovative devices for the diagnosis of ear diseases in the medical and veterinary fields. They own several patents in the audiological field. They create products based on the analysis of the acoustic characteristics of the eardrum and middle ear measured over a broad spectrum of frequencies. Theysupport the diagnosis and monitor the therapy of middle ear pathologies.
- Rubber Conversion — Rubber Conversion provides recycling, product sustainability, custom packaging, environmental impact analysis, material tracking, and online document management. Their customers contact them through phone, email, and online applications.
Simon Fiduciaria nasce nel 1986 per prestare servizi fiduciari a importanti gruppi familiari, imprenditori e professionisti, a livello nazionale ed estero.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Italy, India, Switzerland
Investor stats
- Total investments: 11
- Round size: Seed $1.3M–$7.6M; Pre-Seed $555k–$1.6M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Yoyomove — Yoyomove is a long-term car rental company that offers long-term vehicle rental and flexible mobility solutions designed to simplify your everyday journeys
- Displaid — Displaid abilita la manutenzione predittiva condition-based di tutti i ponti della rete infrastrutturale grazie ad una soluzione di monitoraggio standardizzata, scalabile, e completamente integrata.
- AutoConnexa — Connexa InsTech is a digital and telematics insurance company solution offering unprecedented customer-centricity and flexibility. It was founded in 2021 and its headquarters is located in Bari, Apulia, Italy.
Lumen Ventures is a venture capital firm that focuses on seed investments, early-stage investments, and private equity.
Show more...Investment focus
- Industry: Health Care, Medical, InsurTech
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy
Investor stats
- Total investments: 7
- Round size: Seed $1.3M–$5.3M; Series A $6M–$14M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $29M in 2020
Portfolio highlights
- qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
- Serenis Health — Serenis is a mental health platform that provides psychotherapy with a strong focus on science & impact measurement
- AutoConnexa — Connexa InsTech is a digital and telematics insurance company solution offering unprecedented customer-centricity and flexibility. It was founded in 2021 and its headquarters is located in Bari, Apulia, Italy.
Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Series B, Series A
- Geography: United States, Italy, United Kingdom
Investor stats
- Total investments: 33
- Round size: Series A $2.7M–$43M; Series B $7.9M–$40M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- Roca Therapeutics — First-in-Class Drugs against ocular diseases driven by hyper-vascularization and immuno-suppressive inflammation.A united team creating an innovative therapy to give a new vision to patients.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Primo Capital is a venture capital firm focused on seed and early stage startups. The firm is a multi-fund investment company, with four different investment practices with dedicated funds on specialized strategies. Primo Capital invests in digital/software, new space, climate technology and healthcare.
Show more...Investment focus
- Industry: Software, Aerospace, Information Technology
- Stage:Seed, Series A
- Geography: Italy, United States, United Kingdom
Investor stats
- Total investments: 88
- Round size: Seed $329k–$5.4M; Series A $3.3M–$28M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- D-Orbit — End-to-end services for the New Space industry, including platform engineering, launch and deployment, and decommissioning.
- Leaf Space — Leaf Space offers a global network of ground stations, providing seamless, cost-effective satellite communication with scalable solutions for all mission sizes.
- AIKO - Infinite Ways to Autonomy — We build AI designed for the realities of space. From onboard intelligence to ground operations, our technology turns autonomy into something practical, reliable, and ready to fly.
Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.
Show more...Investment focus
- Industry: Medical, Health Care, Information Technology
- Stage:Seed, Series B
- Geography: Italy
Investor stats
- Total investments: 7
- Round size: Seed $2.2M–$3.8M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- AWorld — AWorld is The Sustainability Platform and Mobile App chosen by the United Nations to support the ActNow Campaign.
- Busforfun — Shared and Green traveling to experience the world of fun#WeTheFun | Busforfun is a young mobility company traveling in a sustainable, safe and low-cost way across Europe. Busforfun vision is a green and shared mobility to experience the world of fun.#WeTheTech | Busforfun is a combination of high tech-startup, e-commerce-platform andtransportation company, Busforfun is going to establish European largest bus network for events in the short time. Thanks to a powerful search engine, business intelligence, an user-friendly booking system and an extensive route network, Busforfun offers travellers the opportunity to experience the world of fun with lower fares.#WeTheGreen | Our low-emission buses comply with the highest safety and environmental standards, so Busforfun offers a sustainable and convenient alternative to cars. With main partner Treedom, Busforfun plants new trees at any travel worldwide.Live Fun Experience in partnership – our concept for successBusforfun provides customers with great offers at lowest budget, through smart network planning, dynamic price management and an adaptive web engine.Busforfun platform is where the innovation and start-up spirit meet the experience and know-how of traditional bus companies and travel agencies.Incredible success can be attributed to the digitalization of old-fashioned bus travel industry: Busforfun has not suppliers or clients: but partners only!
- Faccin Group — Faccin Group leads in manufacturing top tier metal forming & bending machines. Operating as Faccin, Roundo & Boldrini, we offer unparalleled expertise.
UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.
Show more...Investment focus
- Industry: Manufacturing, Renewable Energy, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: Italy, Germany, Spain
Investor stats
- Total investments: 127
- Round size: Post-IPO Debt $40M–$1.4B; Debt Financing $521k–$899M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Banxware — Banxware provides the technology and the funds for business financing of any kind: fully embedded in your platform or as an affiliate solution - all managed by Banxware
- FITT — FITT specializes in thermoplastic fluid transfer and management solutions.
- EuroGroup Laminations — We develop and produce stators and rotors solutions for the energy transition, guaranteeing maximum efficiency and sustainability on a global scale.
NovaCapital invests in the union between entrepreneurs and innovation. It offers international and managerial experience, to transform innovative start-ups and already established companies into structured companies, with managerial skills and an international network.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: Italy, Israel, Austria
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$40M; Pre-Seed $137k–$140k; Series A $5.5M–$22M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- ISAAC — ISAAC is an innovative tech company at the forefront of enhancing structural resilience through advanced active mass damper systems. Specializing in seismic and wind protection, ISAAC's solutions dynamically improve the stability of existing buildings and infrastructure. Utilizing non-invasive retrofitting techniques, our active mass dampersenhance the safety and comfort of structures under dynamic loads without altering their original aesthetics. This approach not only safeguards buildings during natural events but also contributes to greener construction practices by avoiding extensive reconstruction, aligning with sustainable development goals in urban environments.
- Kiutra — We provide cryogen-free cooling systems that simplify low-temperature research. Our solutions offer fast cooldowns, automated control and millikelvin performance ideal for quantum technologies and material science.
- Juniper Biosciences — Juniper Biosciences are at the forefront of transforming healthcare with revolutionary radiopharmaceuticals.
Growth Engine is a Venture Capital holding investing in Pre-Seed and Seed high-potential opportunities. With a current portfolio of more than 40 companies, most of them evolved in successful Scaleups, Growth Engine is a diversified asset class by sector and stage. Growth Engine Shareholders are entrepreneurs who have built companies from the groundup, collectively creating billions in value, and top executives managing companies with multi-billion-dollar valuations.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Secondary Market, Pre-Seed
- Geography: Italy, Mexico, United Kingdom
Investor stats
- Total investments: 46
- Round size: Seed $329k–$4.2M; Pre-Seed $300k–$1.8M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- BonusX — Con l'app BonusX hai un supporto anti-burocrazia tutto l'anno. Accedi a centinaia di bonus e servizi pubblici, senza stress e code.
- CiaoDott —
- Vivaio Ventures — Vivaio Ventures partners with early-stage and creator-led consumer brands to scale food, beverage, and beauty products. We offer capital, consulting, and Made in Italy manufacturing excellence for the next CPG leaders.
Health Care Investor funding in Italy at a glance
Stats across 390 deals from 427 investors.
Access all 427 investors in Italy Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care Investors in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 427 investors investing in Italy Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!